These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37821169)

  • 21. Is glucose control important for prevention of cardiovascular disease in diabetes?
    Mannucci E; Dicembrini I; Lauria A; Pozzilli P
    Diabetes Care; 2013 Aug; 36 Suppl 2(Suppl 2):S259-63. PubMed ID: 23882055
    [No Abstract]   [Full Text] [Related]  

  • 22. [Primary prevention of diabetes mellitus type 2].
    Gallwitz B
    Internist (Berl); 2004 Jun; 45 Suppl 1():S15-22. PubMed ID: 15241504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetes Mellitus and Its Cardiovascular Complications: New Insights into an Old Disease.
    Sardu C; De Lucia C; Wallner M; Santulli G
    J Diabetes Res; 2019; 2019():1905194. PubMed ID: 31236416
    [No Abstract]   [Full Text] [Related]  

  • 24. Cardiac Computed Tomography for Personalized Management of Patients With Type 2 Diabetes Mellitus.
    Cardoso R; Dudum R; Ferraro RA; Bittencourt M; Blankstein R; Blaha MJ; Nasir K; Rajagopalan S; Michos ED; Blumenthal RS; Cainzos-Achirica M
    Circ Cardiovasc Imaging; 2020 Sep; 13(9):e011365. PubMed ID: 32900225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiologist's role in improving glucose control and global cardiovascular risk in patients with type 2 diabetes mellitus.
    Gotto AM
    Am J Cardiol; 2007 Feb; 99(4A):3B-5B. PubMed ID: 17307053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low Perception of Obesity as a Pathological Condition Among Italian Cardiologists.
    Ferrera A; Battistoni A; Lanza O; Rossi C; Tocci G; Volpe M
    High Blood Press Cardiovasc Prev; 2023 Jul; 30(4):351-356. PubMed ID: 37493899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity, Diabetes, and Cardiovascular Diseases: A Compendium.
    Scherer PE; Hill JA
    Circ Res; 2016 May; 118(11):1703-5. PubMed ID: 27230636
    [No Abstract]   [Full Text] [Related]  

  • 29. Emerging glucose-lowering therapies: a guide for cardiologists.
    Gulsin GS; Graham-Brown MPM; Davies MJ; McCann GP
    Heart; 2020 Jan; 106(1):18-23. PubMed ID: 31551292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cardiovascular aspects of diabetes treatment : Finally a reason for cardiologists to be pleased].
    Forst T; Plum-Mörschel L; Weber MM
    Internist (Berl); 2017 Mar; 58(3):293-302. PubMed ID: 28120022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospitalization outcome of heart diseases between patients who received medical care by cardiologists and non-cardiologist physicians: A propensity-score matched study.
    Wu YM; Liu CC; Yeh CC; Sung LC; Lin CS; Cherng YG; Chen TL; Liao CC
    PLoS One; 2020; 15(7):e0235207. PubMed ID: 32629459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mortality and morbidity from smoking-induced cardiovascular diseases: the necessity of the cardiologist's involvement and commitment.
    Milei J; Grana DR
    Int J Cardiol; 1998 Dec; 67(2):95-109. PubMed ID: 9891942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoglycemia from a cardiologist's perspective.
    Sanon VP; Sanon S; Kanakia R; Yu H; Araj F; Oliveros R; Chilton R
    Clin Cardiol; 2014 Aug; 37(8):499-504. PubMed ID: 24895268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cardiologist's view of hypoglycemia.
    Nandish S; Wyatt J; Oliveros R; Zion AS; Lujan M; Chilton R
    Curr Atheroscler Rep; 2010 Mar; 12(2):88-95. PubMed ID: 20425243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular diseases and diabetes mellitus.
    Bandyopadhyay P
    Drug News Perspect; 2006; 19(6):369-75. PubMed ID: 16971974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity and diabetes: the final frontier.
    Rendell MS
    Expert Rev Endocrinol Metab; 2023 Jan; 18(1):81-94. PubMed ID: 36710450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediabetes and macrovascular disease: Review of the association, influence on outcome and effect of treatment.
    Kleinherenbrink W; Osei E; den Hertog HM; Zandbergen AAM
    Eur J Intern Med; 2018 Sep; 55():6-11. PubMed ID: 30007840
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus: A Population-Based Cohort Study Assessing Sex Disparities.
    Wright AK; Kontopantelis E; Emsley R; Buchan I; Mamas MA; Sattar N; Ashcroft DM; Rutter MK
    Circulation; 2019 Jun; 139(24):2742-2753. PubMed ID: 30986362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide-1 receptor agonists for diabetes mellitus: a role in cardiovascular disease.
    Smilowitz NR; Donnino R; Schwartzbard A
    Circulation; 2014 Jun; 129(22):2305-12. PubMed ID: 24891623
    [No Abstract]   [Full Text] [Related]  

  • 40. National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020.
    Adhikari R; Jha K; Dardari Z; Heyward J; Blumenthal RS; Eckel RH; Alexander GC; Blaha MJ
    J Am Heart Assoc; 2022 May; 11(9):e023811. PubMed ID: 35475341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.